GOLDMAN SACHS GROUP INC - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$2,000
-97.3%
10,741
-95.6%
0.00%
Q2 2022$74,000
-39.8%
243,918
+173.6%
0.00%
Q1 2022$123,000
-50.0%
89,162
-56.2%
0.00%
Q4 2021$246,000
-39.4%
203,514
+31.3%
0.00%
Q3 2021$406,000
-52.3%
154,957
-3.6%
0.00%
Q2 2021$852,000
+43.2%
160,759
+82.0%
0.00%
Q1 2021$595,000
+87.1%
88,337
+88.0%
0.00%
Q4 2020$318,000
-77.5%
46,981
-75.0%
0.00%
Q3 2020$1,412,000
-57.7%
188,298
-40.7%
0.00%
-100.0%
Q2 2020$3,338,000
-12.5%
317,564
-26.9%
0.00%0.0%
Q1 2020$3,817,000
+1439.1%
434,209
+544.4%
0.00%
Q4 2019$248,000
-35.6%
67,387
-33.4%
0.00%
Q3 2019$385,000
+120.0%
101,190
+268.3%
0.00%
Q2 2019$175,000
-59.1%
27,473
-46.9%
0.00%
Q1 2019$428,000
+23.3%
51,767
-27.1%
0.00%
Q4 2018$347,000
-42.5%
71,045
+16.2%
0.00%
Q3 2018$603,000
+34.3%
61,121
+86.8%
0.00%
Q2 2018$449,000
+34.4%
32,727
+54.9%
0.00%
Q1 2018$334,000
+42.1%
21,128
+66.5%
0.00%
Q4 2017$235,00012,6910.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CAXTON CORP 1,142,360$7,745,0004.83%
RA Capital Management 10,874,613$73,730,0001.03%
Mesirow Financial Investment Management, Inc. 43,431$294,462,0000.93%
Parkman Healthcare Partners LLC 272,445$1,847,0000.47%
Samsara BioCapital, LLC 601,162$4,076,0000.41%
SILVERARC CAPITAL MANAGEMENT, LLC 102,198$693,0000.40%
Eventide Asset Management 3,450,000$23,391,0000.36%
Orbimed Advisors 5,465,030$37,053,0000.32%
Vivo Capital, LLC 786,883$5,335,0000.24%
Knights of Columbus Asset Advisors LLC 169,429$1,149,0000.12%
View complete list of KALA PHARMACEUTICALS INC shareholders